NCT04802122View on ClinicalTrials.gov

Induction of Anesthesia With Sevoflurane Preserving Spontaneous Breathing: Cardiorespiratory Effects.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 24, 2021

Primary Completion Date

July 13, 2021

Study Completion Date

July 14, 2021

Conditions
Anesthesia Intubation ComplicationCardiovascular ComplicationIntubation
Interventions
DRUG

Sevoflurane inhalant product

Sevoflurane 8% / O2 100% with the vital capacity breathing method (vital capacity induction, VCI) will be used for induction to anesthesia and facilitate endotracheal intubation.

DRUG

Propofol Fresenius

Propofol 1,5mg/Kg, supplemented by fentanyl 2mcg/Kg and rocuronium 0,5mg/Kg and O2 100% will be for induction to anesthesia and facilitate endotracheal intubation. .

Trial Locations (1)

54636

AHEPA University Hospital, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER